Lantern Pharma

Developing drug and companion diagnostics for multi-drug resistant cancers

placeDallas, Texas, United States calendar_todayFounded 2013 groups23 employees language lanternpharma.com

Registered entities

Social engagement

Social engagement: 6.6K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

5 investors on record; lead investors include Bios Partners, Green Park & Golf Ventures.

Investor typeCountShare
Venture capital240%
Angel & family office120%
Accelerator & incubator120%
Other / undisclosed120%

Hiring activity

Hires occasionally

2 roles tracked across 1 of the last 12 months

29 May 2026 · Clinical Trial Manager · Plano, TX

13 May 2026 · Frontend Engineer — AI Drug Discovery Platform, Biopharma Software Engineer, AI Drug Discovery Scientist, Comp

1 Aug 2023 · R SHINY DEVELOPER (Remote position) (Remote)

Based on job postings tracked across public sources.

Recent activity

22 Jun 2026
Event
BIO 2026 Executive Roundtable
17 Jun 2026
Event
From Investor to CEO: A View on Life Sciences Today and Tomorrow
21 May 2026
Product launch
LP-300 in NSCLC
Coming soon